PFKM and colorectal carcinoma: For example, in human colorectal carcinomas, it has been found that TNF receptor-associated protein1 (TRAP1) regulates phosphofructokinase 1 (PFK1) to increase levels of glycolysis, leading to resistance to cetuximab (86).